Densitometria ossea: una breve guida per il nefrologo

Francesco Iannuzzella; Giulio Pioli; Mariarosa Maiorana; Mariacristina Gregorini

doi:10.33393/gcnd.2019.513

Authors

Francesco Iannuzzella Struttura Complessa di Nefrologia e Dialisi, Azienda USL-IRCCS di Reggio Emilia, Italy
Giulio Pioli Ortogeriatria, Azienda USL-IRCCS di Reggio Emilia, Italy
Mariarosa Maiorana Struttura Complessa di Nefrologia e Dialisi, Azienda USL-IRCCS di Reggio Emilia, Italy
Mariacristina Gregorini Struttura Complessa di Nefrologia e Dialisi, Azienda USL-IRCCS di Reggio Emilia, Italy

DOI:

https://doi.org/10.33393/gcnd.2019.513

Keywords:

DXA, MOC, BMD, Bone quality, Bone density, Osteoporosis, CKD-MBD

Abstract

Studies in patients with chronic kidney disease have definitively shown that “dual-energy X-ray absorptiometry” (DXA) may be helpful in assessing fracture risk. Moreover, it is essential to diagnose osteoporosis and evaluate response to treatment. In order to obtain the best utility from DXA, nephrologists need to know the fundamentals of this technique, its indications in clinical practice, and the potential pitfalls in the interpretation of its results. This review will provide an overview of the fundamentals, methodology, and current clinical applications of DXA with special focus on the nephrologist’s perspective.